Mitochondrial Inhibitory Factor 1 (IF1) Is Present in Human Serum and Is Positively Correlated with HDL-Cholesterol
Open Access
- 14 September 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9) , e23949
Abstract
Mitochondrial ATP synthase is expressed as a plasma membrane receptor for apolipoprotein A-I (apoA-I), the major protein component in High Density Lipoproteins (HDL). On hepatocytes, apoA-I binds to cell surface ATP synthase (namely ecto-F1-ATPase) and stimulates its ATPase activity, generating extracellular ADP. This production of extracellular ADP activates a P2Y13-mediated HDL endocytosis pathway. Conversely, exogenous IF1, classically known as a natural mitochondrial specific inhibitor of F1-ATPase activity, inhibits ecto-F1-ATPase activity and decreases HDL endocytosis by both human hepatocytes and perfused rat liver. Since recent reports also described the presence of IF1 at the plasma membrane of different cell types, we investigated whether IF1 is present in the systemic circulation in humans. We first unambiguously detected IF1 in human serum by immunoprecipitation and mass spectrometry. We then set up a competitive ELISA assay in order to quantify its level in human serum. Analyses of IF1 levels in 100 normolipemic male subjects evidenced a normal distribution, with a median value of 0.49 µg/mL and a 95% confidence interval of 0.22–0.82 µg/mL. Correlations between IF1 levels and serum lipid levels demonstrated that serum IF1 levels are positively correlated with HDL-cholesterol and negatively with triglycerides (TG). Altogether, these data support the view that, in humans, circulating IF1 might affect HDL levels by inhibiting hepatic HDL uptake and also impact TG metabolism.Keywords
This publication has 28 references indexed in Scilit:
- Altered lipoprotein metabolism in P2Y13 knockout miceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- P2Y13 Receptor Is Critical for Reverse Cholesterol TransportHepatology, 2010
- Prevalence of cardiovascular risk factors in men with stable coronary heart disease in France and SpainArchives of Cardiovascular Diseases, 2010
- Characterization of endocytic compartments after holo-high density lipoprotein particle uptake in HepG2 cellsHistochemistry and Cell Biology, 2009
- Selected reaction monitoring for quantitative proteomics: a tutorialMolecular Systems Biology, 2008
- Structural and functional characterization of FoF1-ATP synthase on the extracellular surface of rat hepatocytesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2008
- Regulation of Mitochondrial Structure and Function by the F1Fo-ATPase Inhibitor Protein, IF1Cell Metabolism, 2008
- Molecular regulation of HDL metabolism and function: implications for novel therapiesJournal of Clinical Investigation, 2006
- The inhibitor protein of the F1F0-ATP synthase is associated to the external surface of endothelial cellsBiochemical and Biophysical Research Communications, 2005
- An Inhibitor of the F1 Subunit of ATP Synthase (IF1) Modulates the Activity of Angiostatin on the Endothelial Cell SurfaceJournal of Biological Chemistry, 2005